Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Immune Response
100%
Aging Effect
100%
Sex Effect
100%
Confidence Interval
100%
Dose Effect
100%
Trivalent Inactivated Influenza Vaccine
100%
Trivalent Inactivated Vaccine
71%
Age Groups
57%
Half-dose
57%
Geometric Mean Titer
42%
Vaccination
28%
Healthy Adults
28%
Influenza-like Illness
28%
Influenza Vaccine
28%
H3N2
28%
Antibody Titer
28%
Hemagglutination Inhibition Antibody
28%
Vaccine Shortage
28%
Immunogenicity
14%
Headache
14%
Immunization
14%
Dose-response
14%
Vaccine Antigen
14%
Effective Strategies
14%
Public Health Strategies
14%
Non-inferiority
14%
All Ages
14%
Strain Specificity
14%
50 Years Old
14%
Relative Risk
14%
Antibody Response
14%
Myalgia
14%
Trial Registration
14%
Hemagglutination Inhibition
14%
Substantial Reduction
14%
Systemic Response
14%
Arthralgia
14%
Age 50
14%
Medical Visits
14%
Influenza Strains
14%
Injection Site Reaction
14%
Strain Response
14%
B Antigen
14%
New Caledonia
14%
Male Response
14%
Full CI
14%
Fujian
14%
A(H1N1)
14%
Vaccine Adverse Events
14%
Medical Hospitalization
14%
Immunology and Microbiology
Inactivated Vaccine
100%
Immune Response
100%
Influenza Vaccine
100%
Titer
80%
Influenza
60%
Hemagglutination Inhibiting Antibody
40%
Normal Human
40%
Influenza A Virus (H3N2)
40%
Antibody Titer
40%
Immunogenicity
20%
Influenza A Virus (H1N1)
20%
Antibody Response
20%
Dose Response
20%
Hemagglutination Inhibition
20%
Biochemistry, Genetics and Molecular Biology
Titer
100%
Immune Response
100%
Hemagglutination Inhibition
50%
Normal Human
33%
Influenza A Virus (H3N2)
33%
Influenza A Virus (H1N1)
16%
Dose Response
16%
Antibody Response
16%
Immunogenicity
16%